DHR

#103
Danaher Corporation
198.80 USD
+1.76%
Сектор: Здравоохранение
Базовая: USD
Валюта прибыли: USD
Дневной диапазон
197.86
198.81
Годовой диапазон
180.03
242.75
Дневное изменение
+1.76%
Месячное изменение
+5.07%
6-месячное изменение
-3.78%
Годовое изменение
+3.18%
Предыдущее закрытие
195.36
Открыть
198.23
Bid
Ask
Минимум
197.86
High
198.81
Объем
627
Открыть полный график

Financials

Обзор Отчетность Статистика Дивиденды
Квартал Год
  • Market Capitalization 140.58 B
  • Employee 60 K
  • Founded N/A
  • CEO Rainer M. Blair
  • Website www.danaher.com
  • Headquarter Delaware, United States
  • FIGI BBG000BH3JF8
  • Industry Technology
Общий доход
Чистая прибыль
Базовая прибыль на акцию
Общий долг
Свободный денежный поток
Денежные средства и эквиваленты
Коэффициент цена/прибыль
45.33
Коэффициент цена/денежный поток
6.67

Danaher Corporation

Danaher Corporation is an American healthcare company headquartered in Washington, D.C.. It develops products used for advances in biotechnology, life sciences, and diagnostics. The company operates three divisions: biotechnology, which develops products for the development of therapeutics; life sciences, which develops products to identify causes of disease, new therapies, and to test and manufacture new drugs, vaccines and gene editing technologies; and diagnostics, which develops instruments, consumables, and software and services to diagnose diseases. Danaher was founded in 1984 by brothers Steven Rales and Mitchell Rales; it was named after Danaher Creek in Western Montana, where the brothers came up with the idea for the company while fishing. The company is ranked 180th on the Fortune 500 and 241st on the Forbes Global 2000.

Новости